zip >>> 60064
sector >>> Healthcare
fullTimeEmployees >>> 47000
longBusinessSummary >>> AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal BehÃ§et's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrÃ¶m's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Frontier Medicines, Corp.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
city >>> North Chicago
phone >>> 847 932 7900
state >>> IL
country >>> United States
companyOfficers >>> []
website >>> http://www.abbvie.com
maxAge >>> 1
address1 >>> 1 North Waukegan Road
industry >>> Drug Manufacturers—General
previousClose >>> 112.18
regularMarketOpen >>> 112.91
twoHundredDayAverage >>> 96.16533
trailingAnnualDividendYield >>> 0.042075235
payoutRatio >>> 0.9935
volume24Hr >>> None
regularMarketDayHigh >>> 113.1
navPrice >>> None
averageDailyVolume10Day >>> 7909650
totalAssets >>> None
regularMarketPreviousClose >>> 112.18
fiftyDayAverage >>> 106.32576
trailingAnnualDividendRate >>> 4.72
open >>> 112.91
toCurrency >>> None
averageVolume10days >>> 7909650
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> 5.2
exDividendDate >>> 1610582400
beta >>> 0.819327
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 111.47
priceHint >>> 2
currency >>> USD
trailingPE >>> 24.632545
regularMarketVolume >>> 5145750
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 198827229184
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 8320327
priceToSalesTrailing12Months >>> 4.891199
dayLow >>> 111.47
ask >>> 112.89
ytdReturn >>> None
askSize >>> 1300
volume >>> 5145750
fiftyTwoWeekHigh >>> 113.41
forwardPE >>> 9.238721
fromCurrency >>> None
fiveYearAvgDividendYield >>> 4.12
fiftyTwoWeekLow >>> 62.55
bid >>> 112.72
tradeable >>> False
dividendYield >>> 0.0464
bidSize >>> 1000
dayHigh >>> 113.1
exchange >>> NYQ
shortName >>> AbbVie Inc.
longName >>> AbbVie Inc.
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EST
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -18000000
quoteType >>> EQUITY
symbol >>> ABBV
messageBoardId >>> finmb_141885706
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 6.819
beta3Year >>> None
profitMargins >>> 0.18157
enterpriseToEbitda >>> 15.088
52WeekChange >>> 0.28632045
morningStarRiskRating >>> None
forwardEps >>> 12.19
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 1765469952
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 8.65
sharesShort >>> 13334764
sharesPercentSharesOut >>> 0.0076
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.70001
netIncomeToCommon >>> 7324000256
trailingEps >>> 4.572
lastDividendValue >>> 1.3
SandP52WeekChange >>> 0.1436472
priceToBook >>> 13.019654
heldPercentInsiders >>> 0.001
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1601424000
shortRatio >>> 1.87
sharesShortPreviousMonthDate >>> 1606694400
floatShares >>> 1741887191
enterpriseValue >>> 277204860928
threeYearAverageReturn >>> None
lastSplitDate >>> None
lastSplitFactor >>> None
legalType >>> None
lastDividendDate >>> 1610582400
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> 0.225
dateShortInterest >>> 1609372800
pegRatio >>> 0.95
lastCapGain >>> None
shortPercentOfFloat >>> 0.0076
sharesShortPriorMonth >>> 13270647
impliedSharesOutstanding >>> None
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 112.91
logo_url >>> https://logo.clearbit.com/abbvie.com
